Understanding variation in sets of N-of-1 trials

PLoS ONE

Volumn 11, Issue 12, 2016, Pages

  Araujo, Artur ^a   Julious, Steven ^b   Senn, Stephen ^a  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; META ANALYSIS; NULL HYPOTHESIS; RANDOMIZATION; THEORETICAL MODEL; ALGORITHM; CLINICAL TRIAL (TOPIC); MEDICAL RESEARCH; METHODOLOGY; PROCEDURES; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ALGORITHMS; BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; HUMANS; MODELS, STATISTICAL; RESEARCH DESIGN;

EID: 84999749698     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0167167     Document Type: Article

References (67)

1. Keller JL, Guyatt GH, Roberts RS, Adachi JD, Rosenbloom D. An N-of-1 Service-Applying the Scientific Method in Clinical-Practice. Scandinavian Journal of Gastroenterology. 1988; 23:22-9.
2. Guyatt GH, Heyting A, Jaeschke R, Keller J, Adachi JD, Roberts RS. N of 1 randomized trials for investigating new drugs. Controlled clinical trials. 1990; 11(2):88-100. Epub 1990/04/01. PMID: 2161315
3. Guyatt G, Sackett D, Adachi J, Roberts R, Chong J, Rosenbloom D, et al. A clinician's guide for conducting randomized trials in individual patients. Cmaj. 1988; 139(6):497-503. PubMed Central PMCID: PMC1268200. PMID: 3409138
4. Cushny AR, Peebles AR. The action of optimal isomers. II. Hyoscines. Journal of Physiology. 1905; 32:501-10. PMID: 16992790
5. Senn SJ, Richardson W. The first t-test. Statistics in Medicine. 1994; 13(8):785-803. PMID: 8047737
6. Student. The probable error of a mean. Biometrika. 1908; 6:1-25.
7. Fisher RA, editor. The Design of Experiments. Oxford: Oxford; 1990.
8. Senn SJ. Tea for three: on infusions and inferences and milk in first. Significance. 2012; 9(6):30-3.
9. Shelley JH, Baur MP. Paul Martini: the first clinical pharmacologist? Lancet. 1999; 353(9167):1870-3. PMID: 10359428
10. Stoll S. Paul Martini's Methodology of Therapeutic Investigation, 1932. Journal of the Royal Society of Medicine. 2009; 102(11):493-5.
11. Lashner BA, Hanauer SB, Silverstein MD. Optimal timing of colonoscopy to screen for cancer in ulcerative colitis. Annals of internal medicine. 1988; 108(2):274-8. PMID: 3124681
12. Duan N, Kravitz RL, Schmid CH. Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research. Journal of clinical epidemiology. 2013; 66(8 Suppl):S21-8. PubMed Central PMCID: PMCPMC3972259. doi: 10.1016/j.jclinepi.2013.04.006 PMID: 23849149
13. Dugard P, File P, Todman J, Todman JB. Single-case and small-n experimental designs: A practical guide to randomization tests: Routledge; 2012.
14. Auerbach C, Zeitlin W. SSD for R: An R package for analyzing single-subject data: Oxford University Press (UK); 2014.
15. Krishef CH. Fundamental Approaches to Single Subject Design and Analysis: Krieger Publishing Company; 1991.
16. Hersen M, Barlow DH. Single-case experimental designs: strategies for studying behavior change: Pergamon Press; 1976.
17. Senn SJ. Suspended judgment n-of-1 trials. Controlled clinical trials. 1993; 14(1):1-5. PMID: 8440091
18. Rochon J. A statistical model for the "N-of-1" study. Journal of clinical epidemiology. 1990; 43(5):499-508. PMID: 2139111
19. Carlin BP, Louis TA. Bayes and Empirical Bayes Methods for Data Analysis. London: Chapman and Hall; 1996.
20. Senn SJ. Individual response to treatment: is it a valid assumption? BMJ. 2004; 329(7472):966-8. doi: 10.1136/bmj.329.7472.966 PMID: 15499115
21. Dworkin RH, McDermott MP, Farrar JT, O'Connor AB, Senn S. Interpreting patient treatment response in analgesic clinical trials: implications for genotyping, phenotyping, and personalized pain treatment. Pain. 2014; 155(3):457-60. doi: 10.1016/j.pain.2013.09.019 PMID: 24071599
22. Kalow W, Tang BK, Endrenyi L. Hypothesis: comparisons of inter- and intra-individual variations can substitute for twin studies in drug research. Pharmacogenetics. 1998; 8(4):283-9. PMID: 9731714
23. Zucker DR, Ruthazer R, Schmid CH. Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations. Journal of clinical epidemiology. 2010; 63(12):1312-23. Epub 2010/09/25. PubMed Central PMCID: PMC2963698. doi: 10.1016/j. jclinepi.2010.04.020 PMID: 20863658
24. Zucker DR, Schmid CH, McIntosh MW, D'Agostino RB, Selker HP, Lau J. Combining single patient (Nof- 1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment. Journal of clinical epidemiology. 1997; 50(4):401-10. Epub 1997/04/01. PMID: 9179098
25. Senn SJ. Cross-over Trials in Clinical Research. Second ed. Chichester: Wiley; 2002.
26. Senn SJ. Cross-over trials in Statistics in Medicine: the first '25' years. Stat Med. 2006; 25(20):3430-42. doi: 10.1002/sim.2706 PMID: 16955535
27. Jones B, Kenward MG. Design and analysis of cross-over trials. Third ed: CRC Press; 2014.
28. Chen X, Chen P. A comparison of four methods for the analysis of N-of-1 trials. PloS one. 2014; 9(2): e87752. PubMed Central PMCID: PMC3913644. doi: 10.1371/journal.pone.0087752 PMID: 24503561
29. Fisher RA, Mackenzie WA. Studies in crop variation. II. The manurial response of different potato varieties. The Journal of Agricultural Science. 1923; 13(03):311-20.
30. Fisher RA. Statistical Methods for Research Workers. Edinburgh: Oliver and Boyd; 1925.
31. Fisher RA, Wishart J. The Arrangement of Field Experiments and the Statistical Reduction of the Results. 1930.
32. Yates F. The principles of orthogonality and confounding in replicated experiments.(With Seven Textfigures.). The Journal of Agricultural Science. 1933; 23(01):108-45.
33. Nelder JA. The analysis of randomised experiments with orthogonal block structure I. Block structure and the null analysis of variance. Proceedings of the Royal Society of London Series A. 1965; 283:147-62.
34. Nelder JA. The analysis of randomised experiments with orthogonal block structure II. Treatment structure and the general analysis of variance. Proceedings of the Royal Society of London Series A. 1965; 283:163-78.
35. Bailey RA. Design of Comparative Experiments. Gill R, Ross, Silverman, Stein, editor. Cambridge: Cambridge University Press; 2008. 330 p.
36. Bailey RA. A Unified Approach to Design of Experiments. Journal of the Royal Statistical Society Series A-Statistics in Society. 1981; 144:214-23.
37. Senn S. A note regarding 'random effects'. Stat Med. 2014; 33(16):2876-7. doi: 10.1002/sim.5965 PMID: 24898710
38. Der Simonian R, Laird N. Meta-analysis in clinical trials. Controlled clinical trials. 1986; 7(3):177-88. PMID: 3802833
39. Senn SJ. The many modes of meta. Drug Information Journal. 2000; 34:535-49.
40. Senn SJ, Stevens L, Chaturvedi N. Repeated measures in clinical trials: simple strategies for analysis using summary measures. Statistics in Medicine. 2000; 19(6):861-77. PMID: 10734289
41. Nelder JA. A reformulation of linear models. Journal of the Royal Statistical Society A. 1977; 140:48-77.
42. Wilkinson G, Rogers C. Symbolic description of factorial models for analysis of variance. Applied Statistics. 1973:392-9.
43. Senn SJ, Hildebrand H. Crossover trials, degrees of freedom, the carryover problem and its dual. Statistics in Medicine. 1991; 10(9):1361-74. PMID: 1925167
44. Bludowsky A, Kunert J, Stufken J. Optimal Designs for the Carryover Model with Random Interactions Between Subjects and Treatments. Aust N Z J Stat. 2015; 57(4):517-33.
45. Brown H, Prescott R. Applied Mixed Models in Medicine. Second ed. Barnett V, editor. Chichester: Wiley; 2006. 408 p.
46. Verbeke G, Molenberghs G. Linear mixed models for longitudinal data: Springer Science & Business Media; 2009.
47. Pinheiro JC, Bates DM. Mixed-Effects Models in S and S-Plus. Chambers J, Eddy W, Härdle W, Sheather S, Tierney L, editors. New York: Springer; 2000. 1-521 p.
48. Galwey NW. Introduction to mixed modelling: beyond regression and analysis of variance: John Wiley & Sons; 2014.
49. Julious S, Tan SB, Machin D. An Introduction to Statistics in Early Phase Trials. Chichester: Wiley-Blackwell; 2010.
50. Cox DR. The interpretation of the effects of non-additivity in the Latin square. Biometrika. 1958; 45 (1):69-72.
51. Senn SJ. Added Values: Controversies concerning randomization and additivity in clinical trials. Statistics in Medicine. 2004; 23(24):3729-53. doi: 10.1002/sim.2074 PMID: 15580598
52. Senn S. Mastering variation: variance components and personalised medicine. Stat Med. 2015.
53. Patterson S, Jones B. Bioequivalence and Statistics in Clinical Pharmacology Chapman and Hall CRC; 2005.
54. Fleiss JL. A critique of recent research on the two-treatment cross-over design. Controlled clinical trials. 1989; 10:237-43. PMID: 2676339
55. Fleiss JL. Letter to the editor. Biometrics. 1986; 42:449-50. PMID: 3741982
56. Senn SJ. Is the 'simple carry-over' model useful? [published erratum appears in Statistics in Medicine 1992 Sep 15;11(12):1619]. Statistics in Medicine. 1992; 11(6):715-26. PMID: 1594811
57. Miller I, Miller M. John E Freund's Mathematical Statistics with Applications, Seventh edition. Upper Saddle River: Pearson; 2004.
58. Senn S. Various varying variances: The challenge of nuisance parameters to the practising biostatistician. Stat Methods Med Res. 2015; 24(4):403-19. doi: 10.1177/0962280214520728 PMID: 24492794
59. Cox DR, Solomon PJ. Components of Variance. Isham V, Keiding N, Louis TA, Reid N, Tibshirani R, Tong H, editors. Boca Raton: Chapman and Hall; 2003.
60. Viechtbauer W. Conducting meta-analyses in R with the metafor package. Journal of Statistical Software. 2010; 36(3):1-48.
61. Senn S, Weir J, Tsushung AH, Berlin C, Branson M, Glimm E. Creating a suite of macros for meta-analysis in SAS®: A case study in collaboration. Statistics and Probability Letters. 2011; 81(7):842-51.
62. Aitkin M. Meta-analysis by random effect modelling in generalized linear models. Statistics in Medicine. 1999; 18(17-18):2343-51. PMID: 10474144
63. Sheiner LB, Rosenberg B, Melmon KL. Modelling of individual pharmacokinetics for computer-aided drug dosage. Comput Biomed Res. 1972; 5(5):411-59. PMID: 4634367
64. Makubate B, Senn S. Planning and analysis of cross-over trials in infertility. Stat Med. 2010; 29 (30):3203-10. Epub 2010/12/21. doi: 10.1002/sim.3981 PMID: 21170914
65. Keene ON, Jones MR, Lane PW, Anderson J. Analysis of exacerbation rates in asthma and chronic obstructive pulmonary disease: example from the TRISTAN study. Pharm Stat. 2007; 6(2):89-97. doi: 10.1002/pst.250 PMID: 17230434
66. Li J, Gao W, Punja S, Ma B, Vohra S, Duan N, et al. Reporting quality of N-of-1 trials published between 1985 and 2013: a systematic review. Journal of clinical epidemiology. 2016.
67. Vohra S, Shamseer L, Sampson M, Bukutu C, Schmid CH, Tate R, et al. CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement. BMJ. 2015; 350:h1738. doi: 10.1136/bmj.h1738 PMID: 25976398